Microfluidics Market Is Estimated to Grow at US$ 12,927.6 Mn by 2027 during the Forecast Period 2019-2027
Microfluidics Market |
The field of
technology known as microfluidics is concerned with the movement of liquids
through small channels like chips, nozzles, and pumps. Products built on the
microfluidics technology can manipulate and control fluids at the tiniest
scales, from ten to hundreds of micrometres. Designing, producing, and
formulating instruments and assays that deal with extremely small volumes of
fluids—typically in the range of microliters (10-6) to pico liters—is the
foundation of microfluidics (10-12).
Over the forecast
period, a high prevalence rate of lifestyle diseases is anticipated to fuel
market expansion for microfluidics. For instance, 500 million individuals
globally had type 2 diabetes in 2018, according to a report by the American
Diabetes Association titled "Global Prevalence of Type 2 Diabetes for the
Next Ten Years (2018-2028)". Miniaturization, integration, and automation
of priceless complicated chemical, biological, and physical assays are further
factors that are anticipated to support market expansion.
The Global Microfluidics Market Is Estimated To Account For US$ 3,800.4 Mn In Terms Of Value In 2018 And Is Expected To Reach US$ 12,927.6 Mn By The End Of 2027.
Due to advantages including
decreased sample and reagent consumption, shorter analysis times, simplicity of
automation, and the ability to run parallel tests, which reduces assay costs
and time, microfluidics systems are a useful tool for biological and chemical
assays. Due to its cost-effective manufacture, high system integration, and
mobility, it also has enormous potential in next-generation sequencing
point-of-care diagnostic devices, which boosts demand for microfluidics over
the projection period. In terms of value, the Europe region had a 32.2% share
of the worldwide microfluidics market in 2018, followed by North America.
The healthcare research sector in
underdeveloped nations is changing quickly. The development of the worldwide microfluidics
market, however, may be constrained by the absence of a sufficient
infrastructure for healthcare research in emerging regions. Additionally, a
lack of appropriate regulatory framework, improperly developed and implemented
clinical practise guidelines, and a shortage of trained labourers in emerging
nations all have a detrimental effect on market growth. The limited financial
backing and expensive R&D costs for goods based on microfluidics technology
have made it difficult for the global microfluidics market to expand.
Top Manufacturers of Microfluidics Market are- Agilent Technologies,
PerkinElmer Inc., Thermo Fisher Scientific Inc., Qiagen NV, Bio-Rad
Laboratories, Inc., Fluidigm Corporation, Abbott Laboratories, and F.
Hoffmann-La Roche Ltd.
Read Microfluidics
Market Press Release
Comments
Post a Comment